Mondelez International Valuation
Is MDLZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MDLZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MDLZ (CHF61) is trading below our estimate of fair value (CHF134.9)
Significantly Below Fair Value: MDLZ is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MDLZ?
Other financial metrics that can be useful for relative valuation.
What is MDLZ's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$96.51b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.2x |
Enterprise Value/EBITDA | 14.6x |
PEG Ratio | 3.4x |
Price to Earnings Ratio vs Peers
How does MDLZ's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 27.3x | ||
NESN Nestlé | 21x | 5.9% | CHF 235.2b |
LISN Chocoladefabriken Lindt & Sprüngli | 37.7x | 6.2% | CHF 26.0b |
BARN Barry Callebaut | 26.2x | 25.3% | CHF 7.5b |
EMMN Emmi | 24.5x | 13.0% | CHF 4.7b |
MDLZ Mondelez International | 25.5x | 7.5% | CHF 96.5b |
Price-To-Earnings vs Peers: MDLZ is good value based on its Price-To-Earnings Ratio (25.5x) compared to the peer average (27.3x).
Price to Earnings Ratio vs Industry
How does MDLZ's PE Ratio compare vs other companies in the European Food Industry?
Price-To-Earnings vs Industry: MDLZ is expensive based on its Price-To-Earnings Ratio (25.5x) compared to the European Food industry average (14.7x).
Price to Earnings Ratio vs Fair Ratio
What is MDLZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 25.5x |
Fair PE Ratio | 26.5x |
Price-To-Earnings vs Fair Ratio: MDLZ is good value based on its Price-To-Earnings Ratio (25.5x) compared to the estimated Fair Price-To-Earnings Ratio (26.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 61.00 | CHF 66.52 +9.1% | 4.8% | CHF 74.64 | CHF 61.92 | n/a | 24 |
Aug ’25 | CHF 61.00 | CHF 68.73 +12.7% | 5.5% | CHF 77.24 | CHF 61.44 | n/a | 23 |
Jul ’25 | CHF 61.00 | CHF 71.99 +18.0% | 5.0% | CHF 80.76 | CHF 65.50 | n/a | 23 |
Jun ’25 | CHF 61.00 | CHF 73.35 +20.2% | 4.2% | CHF 81.20 | CHF 67.67 | n/a | 24 |
May ’25 | CHF 61.00 | CHF 74.92 +22.8% | 4.7% | CHF 82.72 | CHF 67.10 | n/a | 24 |
Apr ’25 | CHF 61.00 | CHF 75.16 +23.2% | 4.1% | CHF 80.50 | CHF 66.03 | n/a | 25 |
Mar ’25 | CHF 61.00 | CHF 73.50 +20.5% | 4.1% | CHF 78.61 | CHF 64.48 | n/a | 25 |
Feb ’25 | CHF 61.00 | CHF 70.93 +16.3% | 4.5% | CHF 76.34 | CHF 62.61 | n/a | 25 |
Jan ’25 | CHF 61.00 | CHF 68.94 +13.0% | 5.5% | CHF 76.60 | CHF 59.39 | n/a | 24 |
Dec ’24 | CHF 61.00 | CHF 69.21 +13.5% | 6.0% | CHF 77.78 | CHF 60.30 | n/a | 23 |
Nov ’24 | CHF 61.00 | CHF 71.43 +17.1% | 7.7% | CHF 80.80 | CHF 59.01 | n/a | 22 |
Oct ’24 | CHF 61.00 | CHF 75.68 +24.1% | 5.4% | CHF 81.96 | CHF 64.46 | n/a | 23 |
Sep ’24 | CHF 61.00 | CHF 72.58 +19.0% | 5.3% | CHF 78.18 | CHF 61.49 | CHF 61.00 | 21 |
Aug ’24 | CHF 61.00 | CHF 72.39 +18.7% | 5.3% | CHF 77.90 | CHF 61.27 | CHF 61.00 | 21 |
Jul ’24 | CHF 61.00 | CHF 72.18 +18.3% | 5.2% | CHF 76.82 | CHF 62.53 | CHF 61.00 | 21 |
Jun ’24 | CHF 61.00 | CHF 73.06 +19.8% | 5.3% | CHF 77.57 | CHF 63.14 | CHF 61.00 | 21 |
May ’24 | CHF 61.00 | CHF 71.40 +17.1% | 6.4% | CHF 77.07 | CHF 61.84 | CHF 61.00 | 23 |
Apr ’24 | CHF 61.00 | CHF 69.14 +13.4% | 4.5% | CHF 74.29 | CHF 64.08 | CHF 61.00 | 23 |
Mar ’24 | CHF 52.00 | CHF 68.97 +32.6% | 4.8% | CHF 74.24 | CHF 61.25 | CHF 61.00 | 24 |
Feb ’24 | CHF 52.00 | CHF 67.28 +29.4% | 5.1% | CHF 72.70 | CHF 59.98 | CHF 61.00 | 24 |
Jan ’24 | CHF 52.00 | CHF 66.84 +28.5% | 4.4% | CHF 71.36 | CHF 61.16 | CHF 61.00 | 24 |
Dec ’23 | CHF 52.00 | CHF 67.05 +28.9% | 3.7% | CHF 71.75 | CHF 62.31 | CHF 61.00 | 23 |
Nov ’23 | CHF 52.00 | CHF 69.54 +33.7% | 5.1% | CHF 75.10 | CHF 63.09 | CHF 61.00 | 22 |
Oct ’23 | CHF 52.00 | CHF 70.52 +35.6% | 4.9% | CHF 77.19 | CHF 62.53 | CHF 61.00 | 22 |
Sep ’23 | CHF 50.00 | CHF 69.24 +38.5% | 4.8% | CHF 75.53 | CHF 61.19 | CHF 61.00 | 21 |
Analyst Forecast: Target price is less than 20% higher than the current share price.